Search research articles
Contact Us
Filters
Showing results (1-10 of 22) with videos related to
Page
of 3
Sort By:
Therapie
|
September 1, 2005
[Conjugated vaccines]
Bernard Fritzell
Vaccine
|
October 3, 2006
Brief review of the clinical effectiveness of PREVENAR against otitis media
Mark A Fletcher, Bernard Fritzell
Expert Review of Vaccines
|
March 26, 2011
Pneumococcal polysaccharide-protein CRM197 conjugate vaccines, 7- or 9-valent, in the 2 + 1 schedule
Bernard Fritzell, Mark A Fletcher
International Journal of Otolaryngology
|
June 16, 2012
Pneumococcal conjugate vaccines and otitis media: an appraisal of the clinical trials
Mark A Fletcher, Bernard Fritzell
European Journal of Pediatrics
|
December 21, 2002
Time to recommend pneumococcal vaccination for all children in Europe: experience in France
Mark A Fletcher, Robert Tetelboum, Bernard Fritzell
Expert Review of Vaccines
|
March 12, 2010
Advances in pneumococcal vaccines: the 13-valent pneumococcal conjugate vaccine received market authorization in Europe
Ralf R Reinert, Peter Paradiso, Bernard Fritzell
Expert Review of Vaccines
|
September 23, 2006
Pneumococcal conjugate vaccines: emerging clinical information and its implications
Stephen P Lockhart, Jill G Hackell, Bernard Fritzell
Biologicals : Journal of the International Association of Biological Standardization
|
November 28, 2015
Human challenge trials in vaccine development: Strasbourg, September 29 - October 1, 2014
Rebecca L Sheets, Bernard Fritzell, M Teresa Aguado de Ros
Vaccine
|
February 15, 2012
The relationship between pneumococcal serotypes and antibiotic resistance
Jae-Hoon Song, Ron Dagan, Keith P Klugman, et al.
The Journal of Infectious Diseases
|
April 14, 2010
Nasopharyngeal carriage of Streptococcus pneumoniae shortly before vaccination with a pneumococcal conjugate vaccine causes serotype-specific hyporesponsiveness in early infancy
Ron Dagan, Noga Givon-Lavi, David Greenberg, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 22) with videos related to
Sort By:
Page
of 3
Therapie
|
September 1, 2005
[Conjugated vaccines]
Bernard Fritzell
Vaccine
|
October 3, 2006
Brief review of the clinical effectiveness of PREVENAR against otitis media
Mark A Fletcher, Bernard Fritzell
Expert Review of Vaccines
|
March 26, 2011
Pneumococcal polysaccharide-protein CRM197 conjugate vaccines, 7- or 9-valent, in the 2 + 1 schedule
Bernard Fritzell, Mark A Fletcher
International Journal of Otolaryngology
|
June 16, 2012
Pneumococcal conjugate vaccines and otitis media: an appraisal of the clinical trials
Mark A Fletcher, Bernard Fritzell
European Journal of Pediatrics
|
December 21, 2002
Time to recommend pneumococcal vaccination for all children in Europe: experience in France
Mark A Fletcher, Robert Tetelboum, Bernard Fritzell
Expert Review of Vaccines
|
March 12, 2010
Advances in pneumococcal vaccines: the 13-valent pneumococcal conjugate vaccine received market authorization in Europe
Ralf R Reinert, Peter Paradiso, Bernard Fritzell
Expert Review of Vaccines
|
September 23, 2006
Pneumococcal conjugate vaccines: emerging clinical information and its implications
Stephen P Lockhart, Jill G Hackell, Bernard Fritzell
Biologicals : Journal of the International Association of Biological Standardization
|
November 28, 2015
Human challenge trials in vaccine development: Strasbourg, September 29 - October 1, 2014
Rebecca L Sheets, Bernard Fritzell, M Teresa Aguado de Ros
Vaccine
|
February 15, 2012
The relationship between pneumococcal serotypes and antibiotic resistance
Jae-Hoon Song, Ron Dagan, Keith P Klugman, et al.
The Journal of Infectious Diseases
|
April 14, 2010
Nasopharyngeal carriage of Streptococcus pneumoniae shortly before vaccination with a pneumococcal conjugate vaccine causes serotype-specific hyporesponsiveness in early infancy
Ron Dagan, Noga Givon-Lavi, David Greenberg, et al.
Page
of 3